238 related articles for article (PubMed ID: 30409321)
1. Intensity-modulated radiotherapy for paranasal sinuses and base of skull tumors.
Liang ZG; Kusumawidjaja G; Kazmi F; Wee JTS; Chua MLK
Oral Oncol; 2018 Nov; 86():61-68. PubMed ID: 30409321
[TBL] [Abstract][Full Text] [Related]
2. The Role of Radiation Therapy in the Management of Sinonasal and Ventral Skull Base Malignancies.
Wang K; Zanation AM; Chera BS
Otolaryngol Clin North Am; 2017 Apr; 50(2):419-432. PubMed ID: 28104274
[TBL] [Abstract][Full Text] [Related]
3. [Nasal cavity and paranasal sinus cancer].
Peyraga G; Lafond C; Pointreau Y; Giraud P; Maingon P
Cancer Radiother; 2016 Sep; 20 Suppl():S99-S103. PubMed ID: 27528562
[TBL] [Abstract][Full Text] [Related]
4. Comparison of treatment plans using intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for paranasal sinus carcinoma.
Huang D; Xia P; Akazawa P; Akazawa C; Quivey JM; Verhey LJ; Kaplan M; Lee N
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):158-68. PubMed ID: 12694834
[TBL] [Abstract][Full Text] [Related]
5. Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes.
Combs SE; Konkel S; Schulz-Ertner D; Münter MW; Debus J; Huber PE; Thilmann C
Radiat Oncol; 2006 Jul; 1():23. PubMed ID: 16859556
[TBL] [Abstract][Full Text] [Related]
6. The skull base, paranasal sinuses, and related malignancies.
Zender CA; Petruzzelli GJ
Curr Oncol Rep; 2003 Mar; 5(2):147-51. PubMed ID: 12583832
[TBL] [Abstract][Full Text] [Related]
7. Adult rhabdomyosarcoma in the nasal and paranasal sinuses showing complete local response to a combination of chemotherapy and radiotherapy using 3D-CRT and IMRT.
Muto E; Shioyama Y; Nakamura K; Ohga' S; Nomoto S; Toba T; Yoshitake T; Soeda H; Terashima H; Honda H
Fukuoka Igaku Zasshi; 2005 Oct; 96(10):363-9. PubMed ID: 16408493
[TBL] [Abstract][Full Text] [Related]
8. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
Hoppe BS; Wolden SL; Zelefsky MJ; Mechalakos JG; Shah JP; Kraus DH; Lee N
Head Neck; 2008 Jul; 30(7):925-32. PubMed ID: 18302261
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy.
Dirix P; Vanstraelen B; Jorissen M; Vander Poorten V; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):998-1004. PubMed ID: 20338694
[TBL] [Abstract][Full Text] [Related]
10. Dose to the intracranial arteries in stereotactic and intensity-modulated radiotherapy for skull base tumors.
Nieder C; Grosu AL; Stark S; Wiedenmann N; Busch R; Kneschaurek P; Molls M
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1055-9. PubMed ID: 16338100
[TBL] [Abstract][Full Text] [Related]
11. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.
McDonald MW; Liu Y; Moore MG; Johnstone PA
Radiat Oncol; 2016 Feb; 11():32. PubMed ID: 26922239
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the dose constraints for head and neck OARs in the current era of IMRT.
Brodin NP; Tomé WA
Oral Oncol; 2018 Nov; 86():8-18. PubMed ID: 30409324
[TBL] [Abstract][Full Text] [Related]
13. [Intensity modulated radiotherapy (IMRT) of head and neck tumors. Increased biological effectiveness in high-risk situations by "integrated boost" therapy].
Milanovic D; Lohr F; Götte K; Dobler B; Hermann B; Hörmann K; Wenz F
HNO; 2004 Aug; 52(8):729-36. PubMed ID: 15309254
[TBL] [Abstract][Full Text] [Related]
14. Operative management of skull base malignant tumors arising from the nasal cavity and paranasal sinus: recent strategies used in 25 cases.
Jimbo H; Kamata S; Miura K; Asamoto S; Tada S; Endo T; Masubuchi T; Nakamura N; Fushimi C
Neurol Med Chir (Tokyo); 2010 Jan; 50(1):20-6; discussion 26. PubMed ID: 20098020
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic Resection Followed by Proton Therapy With Pencil Beam Scanning for Skull Base Tumors.
Leeman JE; Lee NY; Zhou Y; Neal B; Sine K; Tabar V; Cohen MA
Laryngoscope; 2019 Jun; 129(6):1313-1317. PubMed ID: 30208224
[TBL] [Abstract][Full Text] [Related]
16. IMRT for sinonasal tumors minimizes severe late ocular toxicity and preserves disease control and survival.
Duprez F; Madani I; Morbée L; Bonte K; Deron P; Domján V; Boterberg T; De Gersem W; De Neve W
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):252-9. PubMed ID: 22027259
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy for unresectable sinonasal cancers: dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy.
Orlandi E; Giandini T; Iannacone E; De Ponti E; Carrara M; Mongioj V; Stucchi C; Tana S; Bossi P; Licitra L; Fallai C; Pignoli E
Radiother Oncol; 2014 Nov; 113(2):260-6. PubMed ID: 25467003
[TBL] [Abstract][Full Text] [Related]
18. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.
Nichols RC; Huh SN; Prado KL; Yi BY; Sharma NK; Ho MW; Hoppe BS; Mendenhall NP; Li Z; Regine WF
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):158-63. PubMed ID: 22245197
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Multiple Treatment Planning Techniques for High-Grade Glioma Tumors Near to Critical Organs.
Bas Ayata H; Ceylan C; Kılıç A; Güden M; Engin K
Oncol Res Treat; 2018; 41(9):514-519. PubMed ID: 30086547
[TBL] [Abstract][Full Text] [Related]
20. Chest wall desmoid tumours treated with definitive radiotherapy: a plan comparison of 3D conformal radiotherapy, intensity-modulated radiotherapy and volumetric-modulated arc radiotherapy.
Liu J; Ng D; Lee J; Stalley P; Hong A
Radiat Oncol; 2016 Mar; 11():34. PubMed ID: 26935470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
